ESR1 and cancer: However, several in vivo and in vitro experiments have found that cholesterol may function as a signaling molecule in cancer cells as a cholesterol metabolite, 27-hydroxycholesterol (27HC), was found to act as an antagonist blocking estrogen receptor (ER) activation in the cardiovascular system and also functions as an agonist activating ER+ breast cancer [61].